首页> 外文期刊>Thoracic cancer. >Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer
【24h】

Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer

机译:组织特异性和血浆microRNA谱可能是非小细胞肺癌组织学分类和TNM分期的有前途的生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

In a previous study, we determined that plasma miRNAs are potential biomarkers for cigarette smoking-related lung fibrosis. Herein, we determine whether tissue-specific and plasma miRNA profiles could be promising biomarkers for histological classification and TNM stage in non-small cell lung cancer (NSCLC). Plasma miRNA profiling preoperatively and seven days postoperatively, and cancer and normal tissue miRNA profiling were performed in NSCLC patients and matched healthy controls. There was a > twofold change for all signature miRNAs between the NSCLC patients and controls, with P values of < 0.05. We found that tissue-specific and plasma miR-211-3p, miR-3679-3p, and miR-4787-5p were promising biomarkers of different staging lung squamous cell carcinoma, and miR-3613-3p, miR-3675-3p, and miR-5571-5p were promising biomarkers of different staging lung adenocarcinoma. These results suggest that tissue-specific and plasma miRNAs could be potential biomarkers of histological classification and TNM stage in NSCLC.
机译:在先前的研究中,我们确定血浆miRNA是与吸烟相关的肺纤维化的潜在生物标记。在本文中,我们确定组织特异性和血浆miRNA谱是否可能成为非小细胞肺癌(NSCLC)组织学分类和TNM分期的有前途的生物标志物。术前和术后7天进行血浆miRNA谱分析,并对NSCLC患者和健康对照者进行癌症和正常组织miRNA谱分析。 NSCLC患者和对照之间所有标志性miRNA的变化均>两倍,P值<0.05。我们发现组织特异性和血浆miR-211-3p,miR-3679-3p和miR-4787-5p是不同分期的肺鳞癌的有前途的生物标志物,而miR-3613-3p,miR-3675-3p,和miR-5571-5p是不同分期的肺腺癌的有前途的生物标志物。这些结果表明,组织特异性和血浆miRNA可能是NSCLC组织学分类和TNM分期的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号